{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:04:35Z","timestamp":1781625875264,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Shin-Kong Wu Ho-Su Memorial Hospital and Taipei Medical University","award":["SKH-TMU-112-03"],"award-info":[{"award-number":["SKH-TMU-112-03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiovascular diseases (CVDs) remain the leading cause of morbidity and mortality in end-stage kidney disease patients, with persistently high rates of major adverse cardiovascular events (MACEs). Traditional risk factors such as diabetes and hypertension have limited predictive value in this population, while chronic kidney disease (CKD)-specific factors including inflammation, disordered mineral metabolism, and vascular calcification play significant roles. Therefore, we developed a machine learning-based model incorporating traditional and CKD-specific variables to improve MACEs risk predictions and facilitate early intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively enrolled 412 adults undergoing maintenance hemodialysis (MHD) at a single center between October and December 2018, with follow-up until December 2021 or censoring. Enrolled patients were classified by MACEs occurrences. An elastic-net regularized Cox regression with backward selection was used to identify key MACE predictors, integrating traditional and CKD-specific risk factors. The model performance was validated via leave-one-out cross-validation and area under the receiver operating characteristic curve (AUROC). Standard statistical tests were applied for group comparisons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The elastic-net regression identified 46 key predictors from a high-dimensional dataset. Patients who developed MACEs were older and had higher prevalences of diabetes, hypertension, coronary disease, heart failure, and lower albumin\/cholesterol. A Cox regression with backward selection was used to refine the model to 13 predictors. The final model demonstrated excellent predictive performance, (AUROC\u2009=\u20090.864) (95% CI, 0.8131\u2013 0.9148), effectively stratifying patients into high- and low-risk groups with significant survival differences (log-rank\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The machine learning-based model demonstrated high predictive accuracy for MACEs in MHD patients by integrating both traditional and CKD-specific risk factors, offering a potential tool for early identification and clinical decision-making.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12911-025-03302-2","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T16:47:03Z","timestamp":1764953223000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring prognostic factors on vascular outcomes among maintenance dialysis patients and establishing a prognosis prediction model using machine learning methods"],"prefix":"10.1186","volume":"26","author":[{"given":"Chung-Kuan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zih-Kai","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vy-Khanh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noi","family":"Yar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Tsang","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-Hao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"issue":"2","key":"3302_CR1","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3390\/biomedicines13020367","volume":"13","author":"EM Davies","year":"2025","unstructured":"Davies EM, Buckley BJR, Austin P, Lip GYH, Rao A, McDowell G. Cardiac biomarkers predict major adverse cardiac events (MACE) in incident haemodialysis patients: results from a global federated database. Biomedicines. 2025;13(2):367. https:\/\/doi.org\/10.3390\/biomedicines13020367.","journal-title":"Biomedicines"},{"issue":"6","key":"3302_CR2","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.ekir.2019.03.016","volume":"4","author":"HA Stirnadel-Farrant","year":"2019","unstructured":"Stirnadel-Farrant HA, Karaboyas A, Cizman B, Bieber BA, Kler L, Jones D, et al. Cardiovascular event rates among Hemodialysis patients across geographical regions \u2013 A snapshot from the Dialysis outcomes and practice patterns study (DOPPS). Kidney Int Rep. 2019;4(6):864\u201372. https:\/\/doi.org\/10.1016\/j.ekir.2019.03.016.","journal-title":"Kidney Int Rep"},{"issue":"2","key":"3302_CR3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.6515\/ACS.202403_40(2).20231022A","volume":"40","author":"JY Hsu","year":"2024","unstructured":"Hsu JY, Lee CK, Chaung SY, Cheng CH, Dai LP, Hsieh MY, et al. Incidence and predictors of acute coronary syndrome in patients on maintenance hemodialysis: A prospective cohort study. Acta Cardiol Sin. 2024;40(2):191\u20139. https:\/\/doi.org\/10.6515\/ACS.202403_40(2).20231022A.","journal-title":"Acta Cardiol Sin"},{"issue":"6","key":"3302_CR4","doi-asserted-by":"publisher","first-page":"200","DOI":"10.31083\/j.rcm2506200","volume":"25","author":"S Barbuto","year":"2024","unstructured":"Barbuto S, Hu L, Abenavoli C, Picotti M, Manna G, Nicola L, et al. Coronary artery disease in patients undergoing hemodialysis: A problem that sounds the alarm. Rev Cardiovasc Med. 2024;25(6):200. https:\/\/doi.org\/10.31083\/j.rcm2506200.","journal-title":"Rev Cardiovasc Med"},{"issue":"1","key":"3302_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1159\/000360230","volume":"4","author":"CT Lee","year":"2014","unstructured":"Lee CT, Huang CC, Hsu CY, Chiou TT, Ng HY, Wu CH, et al. Calcification of the aortic arch predicts cardiovascular and all-cause mortality in chronic Hemodialysis patients. Cardiorenal Med. 2014;4(1):34\u201342. https:\/\/doi.org\/10.1159\/000360230.","journal-title":"Cardiorenal Med"},{"key":"3302_CR6","doi-asserted-by":"publisher","first-page":"35375","DOI":"10.1038\/srep35375","volume":"6","author":"A Zhang","year":"2016","unstructured":"Zhang A, Wang S, Li H, Yang J, Wu H. Aortic arch calcification and risk of cardiovascular or all-cause and mortality in Dialysis patients: A meta-analysis. Sci Rep. 2016;6:35375. https:\/\/doi.org\/10.1038\/srep35375.","journal-title":"Sci Rep"},{"issue":"1","key":"3302_CR7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000469716","volume":"42","author":"JC Huang","year":"2017","unstructured":"Huang JC, Kuo IC, Tsai YC, Lee JJ, Lim LM, Chen SC, et al. Heart rate variability predicts major adverse cardiovascular events and hospitalization in maintenance Hemodialysis patients. Kidney Blood Press Res. 2017;42(1):76\u201388. https:\/\/doi.org\/10.1159\/000469716.","journal-title":"Kidney Blood Press Res"},{"issue":"23","key":"3302_CR8","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1161\/01.cir.0000042673.07632.76","volume":"106","author":"L Djouss\u00e9","year":"2002","unstructured":"Djouss\u00e9 L, Rothman KJ, Cupples LA, Levy D, Ellison RC. Serum albumin and risk of myocardial infarction and all-cause mortality in the Framingham offspring study. Circulation. 2002;106(23):2919\u201324. https:\/\/doi.org\/10.1161\/01.cir.0000042673.07632.76.","journal-title":"Circulation"},{"key":"3302_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40364-017-0111-x","volume":"5","author":"SC Chien","year":"2017","unstructured":"Chien SC, Chen CY, Lin CF, Yeh HI. Critical appraisal of the role of serum albumin in cardiovascular disease. Biomark Res. 2017;5:31. https:\/\/doi.org\/10.1186\/s40364-017-0111-x.","journal-title":"Biomark Res"},{"issue":"11","key":"3302_CR10","doi-asserted-by":"publisher","first-page":"254","DOI":"10.5414\/CN109031","volume":"88","author":"DT Gilbertson","year":"2017","unstructured":"Gilbertson DT, Hu Y, Peng Y, Maroni BJ, Wetmore JB. Variability in hemoglobin levels in Hemodialysis patients in the current era: a retrospective cohort study. Clin Nephrol. 2017;88(11):254\u201365. https:\/\/doi.org\/10.5414\/CN109031.","journal-title":"Clin Nephrol"},{"issue":"2","key":"3302_CR11","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/ndt\/gfad166","volume":"39","author":"X Xu","year":"2024","unstructured":"Xu X, Yang Z, Li S, Pei H, Zhao J, Zhang Y, et al. Cut-off values of haemoglobin and clinical outcomes in incident peritoneal dialysis: the PDTAP study. Nephrol Dial Transpl. 2024;39(2):251\u201363. https:\/\/doi.org\/10.1093\/ndt\/gfad166.","journal-title":"Nephrol Dial Transpl"},{"key":"3302_CR12","doi-asserted-by":"publisher","first-page":"6633845","DOI":"10.1155\/2021\/6633845","volume":"2021","author":"W Ruiyan","year":"2021","unstructured":"Ruiyan W, Bin X, Jianhua D, Lei Z, Dehua G, Tang Z. Platelet distribution width and mortality in Hemodialysis patients. Evid Based Complement Alternat Med. 2021;2021:6633845. https:\/\/doi.org\/10.1155\/2021\/6633845.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"16","key":"3302_CR13","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/j.jacc.2007.05.049","volume":"50","author":"DJ Angiolillo","year":"2007","unstructured":"Angiolillo DJ, Bernardo E, Sabat\u00e9 M, Jimenez-Quevedo P, Costa MA, Palazuelos J, et al. Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol. 2007;50(16):1541\u20137. https:\/\/doi.org\/10.1016\/j.jacc.2007.05.049.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"3302_CR14","doi-asserted-by":"publisher","first-page":"sfae044","DOI":"10.1093\/ckj\/sfae044","volume":"17","author":"O Balafa","year":"2024","unstructured":"Balafa O, Fernandez-Fernandez B, Ortiz A, et al. Sex disparities in mortality and cardiovascular outcomes in chronic kidney disease. Clin Kidney J. 2024;17(3):sfae044. https:\/\/doi.org\/10.1093\/ckj\/sfae044.","journal-title":"Clin Kidney J"},{"issue":"12","key":"3302_CR15","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1093\/ckj\/sfad088","volume":"16","author":"M Astley","year":"2023","unstructured":"Astley M, Caskey FJ, Evans M, Dounousi E, Ekart R, Ferro CJ, et al. The impact of gender on the risk of cardiovascular events in older adults with advanced chronic kidney disease. Clin Kidney J. 2023;16(12):2396\u2013404. https:\/\/doi.org\/10.1093\/ckj\/sfad088.","journal-title":"Clin Kidney J"},{"issue":"9","key":"3302_CR16","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.3390\/diagnostics15091063","volume":"15","author":"CW Chuang","year":"2025","unstructured":"Chuang CW, Wu CK, Wu CH, Shia BC, Chen M. Machine learning in predicting cardiac events for ESRD patients: A framework for clinical decision support. Diagnostics (Basel). 2025;15(9):1063. https:\/\/doi.org\/10.3390\/diagnostics15091063.","journal-title":"Diagnostics (Basel)"},{"issue":"5","key":"3302_CR17","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1080\/09537104.2021.1983531","volume":"33","author":"Y Toyoda","year":"2022","unstructured":"Toyoda Y, Tateno K, Takeda Y, Kobayashi Y. Significance of mild thrombocytopenia in maintenance Hemodialysis patients; a retrospective cohort study. Platelets. 2022;33(5):735\u201342. https:\/\/doi.org\/10.1080\/09537104.2021.1983531.","journal-title":"Platelets"},{"issue":"3","key":"3302_CR18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1177\/1358863X21992863","volume":"26","author":"K Hishikari","year":"2021","unstructured":"Hishikari K, Hikita H, Abe F, Ito N, Kanno Y, Iiya M, et al. Risk factors and prognostic impact of post-discharge bleeding after endovascular therapy for peripheral artery disease. Vasc Med. 2021;26(3):281\u20137. https:\/\/doi.org\/10.1177\/1358863X21992863.","journal-title":"Vasc Med"},{"issue":"3","key":"3302_CR19","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1053\/j.ajkd.2013.02.381","volume":"62","author":"KP Ng","year":"2013","unstructured":"Ng KP, Edwards NC, Lip GY, Townend JN, Ferro CJ. Atrial fibrillation in CKD: balancing the risks and benefits of anticoagulation. Am J Kidney Dis. 2013;62(3):615\u201332. https:\/\/doi.org\/10.1053\/j.ajkd.2013.02.381.","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"3302_CR20","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1007\/s40620-022-01413-x","volume":"35","author":"K Parker","year":"2022","unstructured":"Parker K, Hartemink J, Saha A, Mitra R, Lewis P, Power A, et al. A systematic review of the efficacy and safety of anticoagulants in advanced chronic kidney disease. J Nephrol. 2022;35(8):2015\u201333. https:\/\/doi.org\/10.1007\/s40620-022-01413-x.","journal-title":"J Nephrol"},{"issue":"2","key":"3302_CR21","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.nefroe.2020.09.008","volume":"41","author":"M Cano Meg\u00edas","year":"2021","unstructured":"Cano Meg\u00edas M, Guisado Vasco P, Bouarich H, Lara Aguilera I, de Arriba-de la Fuente G, Rodr\u00edguez-Puyol D. Epicardial fat tissue, coronary arterial calcification and mortality in patients with advanced chronic kidney disease and Hemodialysis. Nefrologia (Engl Ed). 2021;41(2):174\u201381. https:\/\/doi.org\/10.1016\/j.nefroe.2020.09.008.","journal-title":"Nefrologia (Engl Ed)"},{"key":"3302_CR22","doi-asserted-by":"publisher","first-page":"999","DOI":"10.2147\/RMHP.S262058","volume":"13","author":"AF Elhabashi","year":"2020","unstructured":"Elhabashi AF, Sulaibeekh L, Seddiq N, Alali S, Abdulmajeed AK, Perez NS. Presepsin level correlates with the development of moderate coronary artery calcifications in Hemodialysis patients: A preliminary cross-section design study. Risk Manag Healthc Policy. 2020;13:999\u20131006. https:\/\/doi.org\/10.2147\/RMHP.S262058.","journal-title":"Risk Manag Healthc Policy"},{"key":"3302_CR23","doi-asserted-by":"publisher","first-page":"1527667","DOI":"10.3389\/fcvm.2025.1527667","volume":"12","author":"S Li","year":"2025","unstructured":"Li S, Wang D, Han X, Zhang D, Deng H, Pan G. Antiplatelet strategy for patients with acute coronary syndrome and chronic kidney disease: a systematic review and meta-analysis. Front Cardiovasc Med. 2025;12:1527667. https:\/\/doi.org\/10.3389\/fcvm.2025.1527667.","journal-title":"Front Cardiovasc Med"},{"key":"3302_CR24","doi-asserted-by":"publisher","unstructured":"Kelly DM, Ademi Z, Doehner W, Lip GYH, Mark P, Toyoda K, et al. Chronic kidney disease and cerebrovascular disease: consensus and guidance from a KDIGO controversies conference. Stroke. 2021;52(7):e328-e346. https:\/\/doi.org\/10.1161\/STROKEAHA.120.029680.","DOI":"10.1161\/STROKEAHA.120.029680"},{"issue":"1","key":"3302_CR25","doi-asserted-by":"publisher","first-page":"3687","DOI":"10.1038\/s41598-024-54375-4","volume":"14","author":"SK Ghosh","year":"2024","unstructured":"Ghosh SK, Khandoker AH. Investigation on explainable machine learning models to predict chronic kidney diseases. Sci Rep. 2024;14(1):3687. https:\/\/doi.org\/10.1038\/s41598-024-54375-4.","journal-title":"Sci Rep"},{"key":"3302_CR26","doi-asserted-by":"publisher","first-page":"205520762312242","DOI":"10.1177\/20552076231224225","volume":"10","author":"JX Zheng","year":"2024","unstructured":"Zheng JX, Li X, Zhu J, Guan SY, Zhang SX, Wang WM. Interpretable machine learning for predicting chronic kidney disease progression risk. Digit Health. 2024;10:20552076231224225. https:\/\/doi.org\/10.1177\/20552076231224225.","journal-title":"Digit Health"},{"issue":"11","key":"3302_CR27","doi-asserted-by":"publisher","first-page":"e1001344","DOI":"10.1371\/journal.pmed.1001344","volume":"9","author":"JB Echouffo-Tcheugui","year":"2012","unstructured":"Echouffo-Tcheugui JB, Kengne AP. Risk models to predict chronic kidney disease and its progression: a systematic review. PLoS Med. 2012;9(11):e1001344. https:\/\/doi.org\/10.1371\/journal.pmed.1001344.","journal-title":"PLoS Med"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-025-03302-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-025-03302-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-025-03302-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:04:29Z","timestamp":1781622269000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12911-025-03302-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3302"],"URL":"https:\/\/doi.org\/10.1186\/s12911-025-03302-2","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"31 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol of the current study was approved by the Institutional Review Board (IRB) of Shin-Kong Wu Ho-Su Memorial Hospital (Number 20221201R) and the IRB of Taipei Medical University Joint Institutional Review Board (Number N202305044). The conduct of this study adhered to the principles of the Declaration of Helsinki. Informed consent was waived by the IRB committees of Shin-Kong Wu Ho-Su Memorial Hospital and Taipei Medical University Joint Institutional Review Board due to the retrospective nature of the study and because all examinations were part of routine care.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The sponsors had no role in the study design, data collection, analysis, and result interpretation of this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Sponsor\u2019s role"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}